Clinical profile of simultaneous bilateral optic neuritis in adults

被引:39
作者
de la Cruz, J [1 ]
Kupersmith, MJ [1 ]
机构
[1] Roosevelt Hosp, Albert Einstein Sch Med, New York Eye & Ear Infirm, Neuroophthalmol Serv, New York, NY 10019 USA
关键词
D O I
10.1136/bjo.2005.085399
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: To establish the clinical profile of simultaneous bilateral optic neuritis in adults, the efficacy of steroid therapy, extent of visual recovery, and neurological outcome. Methods: The authors performed a retrospective review of records of patients referred to a neuro-ophthalmology service with acute bilateral optic neuritis from 2000-4. Exclusion criteria included previous multiple sclerosis or myelopathy, known systemic disorders or medications associated with optic neuropathy, uveitis, or neoplasm. Patients received intravenous methylprednisolone followed by oral prednisone. Visual acuity (logMAR conversion), mean deviation (dB) for visual fields, percentage of Ishihara plates seen, ophthalmoscopy, and neurological evaluation were recorded at baseline and at 6 months or 12 months. Owing to strong correlation for visual loss between eyes, the results for the worse eye in each patient were analysed. Results: 11 men and four women, with an age range of 18 64 years, had bilateral decreased vision, 12 with pain on eye movement. Except for one patient, no aetiology was found. All patients had normal neurological evaluations, average visual acuity 1.71 (SD 0.55), colour vision 2.7% (SD 9.9%), and mean deviation -25.35 dB (SD -7.95 dB). Both optic nerves showed abnormal signal on magnetic resonance imaging. 14 patients improved and their last average visual acuity, colour vision, and mean deviation were 0.36 (SD 0.54), 69% (SD 46%), and -7.05 dB (SD 8.40 dB), respectively. No patient developed a neurological problem during the follow up with a mean of 11 months. Conclusion: Idiopathic acute bilateral optic neuritis without myelopathy occasionally occurs in adults. Vision recovers with corticosteroid therapy and during the first year neurological dysfunction will frequently not occur.
引用
收藏
页码:551 / 554
页数:4
相关论文
共 14 条
  • [1] THE CLINICAL PROFILE OF OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL
    BECH, RW
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (12) : 1673 - 1678
  • [2] BECK RW, 1988, ARCH OPHTHALMOL-CHIC, V106, P1051
  • [3] OPTIC NEURITIS TREATMENT TRIAL - ONE-YEAR FOLLOW-UP RESULTS
    BECK, RW
    CLEARY, PA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (06) : 773 - 775
  • [4] BECK RW, 1993, OPHTHALMOLOGY, V100, P691
  • [5] Boomer Jeffrey A, 2003, Semin Ophthalmol, V18, P174, DOI 10.1080/08820530390895172
  • [6] Steroid-responsive HIV optic neuropathy
    Burton, BJL
    Leff, AP
    Plant, GT
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 1998, 18 (01) : 25 - 29
  • [7] Chronic relapsing inflammatory optic neuropathy (CRION)
    Kidd, D
    Burton, B
    Plant, GT
    Graham, EM
    [J]. BRAIN, 2003, 126 : 276 - 284
  • [8] Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance
    Kupersmith, MJ
    Alban, T
    Zeiffer, B
    Lefton, D
    [J]. BRAIN, 2002, 125 : 812 - 822
  • [9] AUTOIMMUNE OPTIC NEUROPATHY - EVALUATION AND TREATMENT
    KUPERSMITH, MJ
    BURDE, RM
    WARREN, FA
    KLINGELE, TG
    FROHMAN, LP
    MITNICK, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (11) : 1381 - 1386
  • [10] MANDLER R, 1993, ANN NEUROL, P162